Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case-control study

Cancer Epidemiology

Volumn 34, Issue 3, 2010, Pages 298-302

  Akkiz, Hikmet ^a   Bayram, Süleyman ^a   Bekar, Aynur ^a   Akgöllü, Ersin ^a   Özdil, Burhan ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Cyclin D1 G870A polymorphism; Hepatocellular carcinoma; PCR RFLP; Single nucleotide polymorphism; Susceptibility

Indexed keywords

CYCLIN D1;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CYCLIN D1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION; POPULATION SURVEILLANCE; RISK FACTORS; TURKEY; YOUNG ADULT;

EID: 77952241395     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2010.02.011     Document Type: Article

References (40)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Farazi P.A., and DePinho R.A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6 (2006) 674-687
3. El-Serag H.B., and Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132 (2007) 2557-2576
4. Kim Y.J., and Lee H.S. Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Intervirology 48 (2005) 10-15
5. Kato N., Ji G., Wang Y., Baba M., Hoshida Y., Otsuka M., et al. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C. Hepatology 42 (2005) 846-853
6. Knudsen K.E. The cyclin D1b splice variant: an old oncogene learns new tricks. Cell Div 24 (2006) 1-15
7. Gautschi O., Ratschiller D., Gugger M., Betticher D.C., and Heighway J. Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. Lung Cancer 55 (2007) 1-14
8. Sawa H., Ohshima T.A., Ukita H., Murakami H., Chiba Y., Kamada H., et al. Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene 16 (1998) 1701-1712
9. Hosokawa Y., Gadd M., Smith A.P., Koerner F.C., Schmidt E.V., and Arnold A. Cyclin D1 (PRAD1) alternative transcript b: full-length cDNA cloning and expression in breast cancers. Cancer Lett 113 (1997) 123-130
10. Betticher D.C., Thatcher N., Altermatt H.J., Hoban P., Ryder W.D., and Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11 (1995) 1005-1011
11. Knudsen K.E., Diehl J.A., Haiman C.A., and Knudsen E.S. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25 (2006) 1620-1628
12. Guo Y., Yang K., Harwalkar J., Nye J.M., Mason D.R., Garrett M.D., et al. Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis. Oncogene 24 (2005) 2599-2612
13. Lewis R.C., Bostick R.M., Xie D., Deng Z., Wargovich M.J., Fina M.F., et al. Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas. Cancer Res 63 (2003) 8549-8553
14. Kong S., Wei Q., Amos C.I., Lynch P.M., Levin B., Zong J., et al. Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst 93 (2001) 1106-1108
15. Le Marchand L., Seifried A., Lum-Jones A., Donlon T., and Wilkens L.R. Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer. J Am Med Assoc 290 (2003) 2843-2848
16. Porter T.R., Richards F.M., Houlston R.S., Evans D.G., Jankowski J.A., Macdonald F., et al. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 21 (2002) 1928-1933
17. Zheng Y., Shen H., Sturgis E.M., Wang L.E., Eicher S.A., Strom S.S., et al. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis 22 (2001) 1195-1199
18. Rydzanicz M., Golusinski P., Mielcarek-Kuchta D., Golusinski W., and Szyfter K. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx. Eur Arch Otorhinolaryngol 263 (2006) 43-48
19. Nishimoto I.N., Pinheiro N.A., Rogatto S.R., Carvalho A.L., Simpson A.J., Caballero O.L., et al. Cyclin D1 gene polymorphism as a risk factor for squamous cell carcinoma of the upper aerodigestive system in non-alcoholics. Oral Oncol 40 (2004) 604-610
20. Wang L., Habuchi T., Takahashi T., Mitsumori K., Kamoto T., Kakehi Y., et al. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis 23 (2002) 257-264
21. Yu J., Habuchi T., Tsuchiya N., Nakamura E., Kakinuma H., Horikawa Y., et al. Association of the cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinoma. J Urol 172 (2004) 2410-2413
22. Wang L., Habuchi T., Mitsumori K., Li Z., Kamoto T., Kinoshita H., et al. Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism. Int J Cancer 103 (2003) 116-120
23. Krippl P., Langsenlehner U., Renner W., Yazdani-Biuki B., Wolf G., Wascher T.C., et al. The 870G > A polymorphism of the cyclin D1 gene is not associated with breast cancer. Breast Cancer Res Treat 82 (2003) 165-168
24. Grieu F., Malaney S., Ward R., Joseph D., and Iacopetta B. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers. Anticancer Res 23 (2003) 4257-4259
25. Yu C., Lu W., Tan W., Xing D., Liang G., Miao X., et al. Lack of association between CCND1 G870A polymorphism and risk of esophageal squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev 12 (2003) 176
26. Sanyal S., Festa F., Sakano S., Zhang Z., Steineck G., Norming U., et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25 (2004) 729-734
27. Cortessis V.K., Siegmund K., Xue S., Ross R.K., and Yu M.C. A case-control study of cyclin D1 CCND1 870A > G polymorphism and bladder cancer. Carcinogenesis 24 (2003) 1645-1650
28. Zhang Y.J., Chen S.Y., Chen C.J., and Santella R.M. Polymorphisms in cyclin D1 gene and hepatocellular carcinoma. Mol Carcinog 33 (2002) 125-129
29. Tsai J.F., Chang W.Y., Jeng J.E., Ho M.S., Lin Z.Y., Tsai J.H., and Hepatitis B. C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver 14 (1994) 98-102
30. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Peitroni M.C., and Williams R. Transection of the esophagus for bleeding esophageal varices. Br J Surg 60 (1973) 646-649
31. Sambrook J., Frits E.F., and Mnniatis T. Moleculer cloning: A laboratory manual. second ed. (1989), Cold Spring Harbor, New York
32. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
33. Hall M., and Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv Cancer Res 68 (1996) 67-108
34. Hinds P.W., Dowdy S.F., Eaton E.N., Arnold A., and Weinberg R.A. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A 91 (1994) 709-713
35. Donnellan R., and Chetty R. Function of a human cyclin gene as an oncogene. Mol Pathol 51 (1998) 1-7
36. Zhang Y.J., Jiang W., Chen C.J., Lee C.S., Kahn S.M., Santella R.M., et al. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 196 (1993) 1010-1016
37. Nishida N., Fukuda Y., Komeda T., Kita R., Sando T., Furukawa M., et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 54 (1994) 3107-3110
38. Solomon D.A., Wang Y., Fox S.R., Lambeck T.C., Giesting S., Lan Z., et al. Cyclin D1 splice variants: differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 278 (2003) 30339-30347
39. Holley S.L., Parkes G., Matthias C., Bockmühl U., Jahnke V., Leder K., et al. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. Am J Pathol 159 (2001) 1917-1924
40. Bala S., and Peltomäki P. CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. Cancer Res 61 (2001) 6042-6045